Skin Grafts Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Skin Grafts Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Skin Grafts Market Size

Skin Grafts Market size is anticipated to record stellar progression from 2024 to 2032 due to the surging number of R&D investments and innovations in dermatomes.
 

According to WHO, burns pose a significant global health challenge, resulting in around 180,000 deaths each year. The majority of these fatalities occur in low- and middle-income countries, with almost two-thirds concentrated in the WHO African and South-East Asia regions. Burns, whether caused by fire, chemicals, or accidents, often require extensive surgical intervention, including skin grafting, to facilitate wound closure and tissue regeneration. Similarly, traumatic injuries resulting from accidents or surgical procedures necessitate the use of skin grafts to repair damaged tissue and promote healing. As the incidence of burns and trauma continues to rise, the demand for skin grafts is expected to escalate.
 

The industry is experiencing further growth, driven by advancements in regenerative medicine. Technological innovations have revolutionized the field, enabling the development of skin grafts with enhanced regenerative properties. These grafts promote faster wound healing, reduce the risk of infection, and improve overall patient outcomes.
 

Skin Grafts Market Trends

Skin grafts are witnessing expanding applications in dermatological and cosmetic surgeries. They are commonly used in procedures such as Mohs surgery, skin cancer excision, and cosmetic reconstructive surgeries to repair damaged or aesthetically compromised skin. Additionally, advancements in tissue engineering and grafting techniques have paved the way for innovative applications in cosmetic procedures, including scar revision and tissue augmentation. As dermatological and cosmetic surgeries continue to evolve, this will shape the industry outlook.
 

Skin Grafts Market Analysis

The split-thickness segment will gain substantial impetus through 2032 owing to their increasing importance in reconstructive ladder. Lately, healthcare organizations are increasingly preferring split-thickness solutions as they help cover large areas of missing or damaged skin. The increasing burden of skin loss driven by the rising prevalence of infection and reconstructive surgeries will further drive the product uptake.
 

The skin cancer application segment share will expand exponentially from 2024 to 2032, ascribed to the rising advancements to cater to the soaring needs for skin cancer surgery. The rising cases of skin cancer globally will also accelerate the adoption of skin grafts. As per the American Academy of Dermatology Association, nearly 9,500 people are diagnosed with skin cancer in the U.S. every day.
 

North America skin grafts industry size is expected to record considerable traction through 2032 on account of the growing number of hospitals, dermatology clinics, and ambulatory surgical centers. The higher purchasing power and the ready adoption of novel technologies have pushed several leading players in the region to expand their footprint. The increasing threat of burns wounds and skin cancer in the U.S. and Canada will also support the regional industry expansion.
 

Skin Grafts Market Share

Some of the leading skin grafts industry companies are

• Zimmer Biomet
• B. Braun Melsungen AG
• Avita Medical
• Integra Lifesciences Corporation
• Surtex Instruments Limited
• Nouvag AG
• MiMedx
• Organogenesis Inc.
• De Soutter Medical Limited
• Tissue Regenix
   

These players are emphasizing on R&D efforts and investing in new partnerships to gain a competitive advantage.
 

Skin Grafts Industry News

In 2023, Integra LifeSciences Holdings Corporation, signed a definitive agreement to purchase Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company. The acquisition was valued at $275 million in cash at closing, with an additional $5 million contingent upon meeting specific regulatory milestones.

What Information does this report contain?